Bedford Laboratories has recalled one lot of preservative-free Methotrexate for Injection because the active ingredient was contaminated with low levels of the preservative ethylene glycol. The affected lot is #859142, with a September 2007 expiry. Health professionals should not distribute the 1-gm vials (NDC 55390-143-01) and should contact Bedford Labs for return instructions. The complete FDA MedWatch safety summary is at http://www.fda.gov/medwatch/safety/2005/safety05.htm#Methotrexate.
Mental Health and CBD: What's the Latest Info
October 27th 2022Drug Topics® is joined by Dr. Alex Capano, Chief Science Officer at Ananda Professional to discuss what CBD is used for mental health, where research should go next, and how to ensure that patients are getting effective CBD products.
2 Clarke Drive
Cranbury, NJ 08512